Global DPT Vaccines 麻豆原创 Research Report 2025

Publication ID:

PB503261845

Publication Date:

March 24, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for DPT Vaccines was valued at US$ 5555 million in the year 2024 and is projected to reach a revised size of US$ 7043 million by 2031, growing at a CAGR of 3.5% during the forecast period.
The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DPT Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DPT Vaccines.
The DPT Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DPT Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Age, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DPT Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Age, and by regions.
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
DTaP
Tdap
DTwP
Segment by Age
12 Months Below
12 Months Above
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DPT Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Age, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 DPT Vaccines 麻豆原创 Overview
1.1 Product Definition
1.2 DPT Vaccines by Type
1.2.1 Global DPT Vaccines 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 DTaP
1.2.3 Tdap
1.2.4 DTwP
1.3 DPT Vaccines by Age
1.3.1 Global DPT Vaccines 麻豆原创 Value by Age (2024 VS 2031)
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global DPT Vaccines 麻豆原创 Size Estimates and Forecasts
1.4.1 Global DPT Vaccines Revenue 2020-2031
1.4.2 Global DPT Vaccines Sales 2020-2031
1.4.3 Global DPT Vaccines 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 DPT Vaccines 麻豆原创 Competition by Manufacturers
2.1 Global DPT Vaccines Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global DPT Vaccines Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global DPT Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of DPT Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of DPT Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DPT Vaccines, Product Type & Application
2.7 Global Key Manufacturers of DPT Vaccines, Date of Enter into This Industry
2.8 Global DPT Vaccines 麻豆原创 Competitive Situation and Trends
2.8.1 Global DPT Vaccines 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest DPT Vaccines Players 麻豆原创 Share by Revenue
2.8.3 Global DPT Vaccines 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global DPT Vaccines 麻豆原创 Scenario by Region
3.1 Global DPT Vaccines 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global DPT Vaccines Sales by Region: 2020-2031
3.2.1 Global DPT Vaccines Sales by Region: 2020-2025
3.2.2 Global DPT Vaccines Sales by Region: 2026-2031
3.3 Global DPT Vaccines Revenue by Region: 2020-2031
3.3.1 Global DPT Vaccines Revenue by Region: 2020-2025
3.3.2 Global DPT Vaccines Revenue by Region: 2026-2031
3.4 North America DPT Vaccines 麻豆原创 Facts & Figures by Country
3.4.1 North America DPT Vaccines 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America DPT Vaccines Sales by Country (2020-2031)
3.4.3 North America DPT Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe DPT Vaccines 麻豆原创 Facts & Figures by Country
3.5.1 Europe DPT Vaccines 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe DPT Vaccines Sales by Country (2020-2031)
3.5.3 Europe DPT Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DPT Vaccines 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific DPT Vaccines 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific DPT Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific DPT Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America DPT Vaccines 麻豆原创 Facts & Figures by Country
3.7.1 Latin America DPT Vaccines 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America DPT Vaccines Sales by Country (2020-2031)
3.7.3 Latin America DPT Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DPT Vaccines 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa DPT Vaccines 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa DPT Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa DPT Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global DPT Vaccines Sales by Type (2020-2031)
4.1.1 Global DPT Vaccines Sales by Type (2020-2025)
4.1.2 Global DPT Vaccines Sales by Type (2026-2031)
4.1.3 Global DPT Vaccines Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global DPT Vaccines Revenue by Type (2020-2031)
4.2.1 Global DPT Vaccines Revenue by Type (2020-2025)
4.2.2 Global DPT Vaccines Revenue by Type (2026-2031)
4.2.3 Global DPT Vaccines Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global DPT Vaccines Price by Type (2020-2031)
5 Segment by Age
5.1 Global DPT Vaccines Sales by Age (2020-2031)
5.1.1 Global DPT Vaccines Sales by Age (2020-2025)
5.1.2 Global DPT Vaccines Sales by Age (2026-2031)
5.1.3 Global DPT Vaccines Sales 麻豆原创 Share by Age (2020-2031)
5.2 Global DPT Vaccines Revenue by Age (2020-2031)
5.2.1 Global DPT Vaccines Revenue by Age (2020-2025)
5.2.2 Global DPT Vaccines Revenue by Age (2026-2031)
5.2.3 Global DPT Vaccines Revenue 麻豆原创 Share by Age (2020-2031)
5.3 Global DPT Vaccines Price by Age (2020-2031)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Pasteur DPT Vaccines Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK DPT Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Company Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 KM Biologics
6.4.1 KM Biologics Company Information
6.4.2 KM Biologics Description and Business Overview
6.4.3 KM Biologics DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 KM Biologics DPT Vaccines Product Portfolio
6.4.5 KM Biologics Recent Developments/Updates
6.5 Wuhan Institute of Biological Products
6.5.1 Wuhan Institute of Biological Products Company Information
6.5.2 Wuhan Institute of Biological Products Description and Business Overview
6.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Company Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Walvax Biotechnology DPT Vaccines Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Chengdu Institute of Biological Products
6.7.1 Chengdu Institute of Biological Products Company Information
6.7.2 Chengdu Institute of Biological Products Description and Business Overview
6.7.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.8 Minhai Biotechnology
6.8.1 Minhai Biotechnology Company Information
6.8.2 Minhai Biotechnology Description and Business Overview
6.8.3 Minhai Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Minhai Biotechnology DPT Vaccines Product Portfolio
6.8.5 Minhai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DPT Vaccines Industry Chain Analysis
7.2 DPT Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DPT Vaccines Production Mode & Process Analysis
7.4 DPT Vaccines Sales and 麻豆原创ing
7.4.1 DPT Vaccines Sales Channels
7.4.2 DPT Vaccines Distributors
7.5 DPT Vaccines Customer Analysis
8 DPT Vaccines 麻豆原创 Dynamics
8.1 DPT Vaccines Industry Trends
8.2 DPT Vaccines 麻豆原创 Drivers
8.3 DPT Vaccines 麻豆原创 Challenges
8.4 DPT Vaccines 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.